Canada
· Delayed Price · Currency is CAD Quantum BioPharma Statistics
Total Valuation
CSE:QNTM has a market cap or net worth of CAD 21.45 million. The enterprise value is 10.56 million.
| Market Cap | 21.45M |
| Enterprise Value | 10.56M |
Important Dates
The last earnings date was Friday, March 7, 2025.
| Earnings Date | Mar 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:QNTM has 1.93 million shares outstanding. The number of shares has increased by 86.67% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.93M |
| Shares Change (YoY) | +86.67% |
| Shares Change (QoQ) | +115.92% |
| Owned by Insiders (%) | 16.84% |
| Owned by Institutions (%) | 3.92% |
| Float | 1.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.34 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.52 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.93 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.80 |
| Quick Ratio | 1.65 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -493.02 |
Financial Efficiency
Return on equity (ROE) is -127.76% and return on invested capital (ROIC) is -83.52%.
| Return on Equity (ROE) | -127.76% |
| Return on Assets (ROA) | -58.82% |
| Return on Invested Capital (ROIC) | -83.52% |
| Return on Capital Employed (ROCE) | -155.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.20M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.50% in the last 52 weeks. The beta is 0.56, so CSE:QNTM's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -80.50% |
| 50-Day Moving Average | 8.82 |
| 200-Day Moving Average | 8.26 |
| Relative Strength Index (RSI) | 61.04 |
| Average Volume (20 Days) | 12,694 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -203,984 |
| Operating Income | -23.42M |
| Pretax Income | -21.46M |
| Net Income | -20.44M |
| EBITDA | -22.72M |
| EBIT | -23.42M |
| Earnings Per Share (EPS) | -17.97 |
Balance Sheet
The company has 10.36 million in cash and 968,065 in debt, giving a net cash position of 9.39 million or 4.87 per share.
| Cash & Cash Equivalents | 10.36M |
| Total Debt | 968,065 |
| Net Cash | 9.39M |
| Net Cash Per Share | 4.87 |
| Equity (Book Value) | 15.02M |
| Book Value Per Share | 8.34 |
| Working Capital | 7.73M |
Cash Flow
In the last 12 months, operating cash flow was -9.89 million and capital expenditures -1.44 million, giving a free cash flow of -11.34 million.
| Operating Cash Flow | -9.89M |
| Capital Expenditures | -1.44M |
| Free Cash Flow | -11.34M |
| FCF Per Share | -5.88 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:QNTM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -86.67% |
| Shareholder Yield | -86.67% |
| Earnings Yield | -95.29% |
| FCF Yield | -52.86% |
Stock Splits
The last stock split was on August 15, 2024. It was a reverse split with a ratio of 0.0153846154.
| Last Split Date | Aug 15, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0153846154 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |